ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.

ClinicalTrials.gov ID: NCT05169710

Public ClinicalTrials.gov record NCT05169710. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 9:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-region, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating SEP-4199 Controlled Release (CR) for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression)

Study identification

NCT ID
NCT05169710
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
83 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • SEP-4199 CR 200 mg Drug
  • SEP-4199 CR 400 mg Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 20, 2021
Primary completion
Oct 17, 2023
Completion
Oct 17, 2023
Last update posted
Oct 2, 2024

2021 – 2023

United States locations

U.S. sites
34
U.S. states
17
U.S. cities
33
Facility City State ZIP Site status
University of Alabama at Birmingham Huntsville Regional Medical Campus Huntsville Alabama 35801
Sanro Clinical Research Group LLC Bryant Arkansas 72022
Advanced Research Center, Inc. Anaheim California 92805
Sun Valley Research Center Imperial California 92251
Clinical innovations, Inc. Riverside California 92506
Siyan Clinical Research Santa Rosa California 95401
Collaborative Neuroscience Research, LLC Torrance California 90502
Vertex Research Group Clermont Florida 34711
Sarkis Clinical Trials Gainesville Florida 32607
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32256
Premier Clinical Research Institute, Inc. Miami Florida 33122
Central Miami Medical Institute Miami Florida 33125
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801
GCP Clinical Research LLC Tampa Florida 33609
Atlanta Behavioral Research, LLC Atlanta Georgia 30338
Psych Atlanta, P.C. Marietta Georgia 30060
AMR Conventions Research Warrenville Illinois 60555
Dept. of Psychiatry & Behavioral Sciences, University of Louisville School of Medicine Louisville Kentucky 40202
St. Charles Psychiatric Associates / Midwest Research Group Saint Charles Missouri 63304
Alivation Research, LLC Lincoln Nebraska 68526
Center for Emotional Fitness Cherry Hill New Jersey 08002
Global Medical Institutes, LLC Princeton New Jersey 08540
UB Department of Psychiatry Buffalo New York 14215
Finger Lakes Clinical Research Rochester New York 14618
Richmond Behavioral Associates ERG Clinical Research - New York PLLC Staten Island New York 10312
New Hope Clinical Research Charlotte North Carolina 28211
Quest Therapeutics of Avon Lake Avon Lake Ohio 44012
Neuro-Behavioral Clinical Research, Inc North Canton Ohio 44720
Sooner Clinical Research Oklahoma City Oklahoma 73112
Lehigh Center for Clinical Research, LLC Allentown Pennsylvania 18104
Community Clinical Research, Inc. Austin Texas 78754
UTHealth Science Center at Houston Houston Texas 77054
Family Psychiatry of The Woodlands The Woodlands Texas 77381
Integrated Clinical Research St. George Utah 84770

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 55 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05169710, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 2, 2024 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05169710 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →